GlassScriptPhysician profile
Timu Niratsuwan Kwi
NPI 1164465415
$1,184.29
in general payments reported to CMS, 2019-2025
19 companies · $83.96 in 2025
The $83.96 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $155 · 2021: $129 · 2022: $170 · 2023: $150 · 2024: $134 · 2025: $83.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $327.06 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $116.30 | 2019-2023 | Shingrix, Arexvy |
| Lilly USA, LLC | $101.79 | 2019-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.09 | 2019-2023 | Jardiance |
| Ironshore Pharmaceuticals INC. | $87.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $75.65 | 2019-2025 | Airsupra, Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $68.25 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $48.77 | 2019-2024 | Capvaxive |
| Janssen Pharmaceuticals, INC | $38.53 | 2019-2021 | |
| Sanofi Pasteur INC. | $33.26 | 2021-2022 | |
| Corium, LLC | $31.67 | 2025 | Azstarys |
| Amgen INC. | $31.42 | 2019-2022 | |
| Exact Sciences Corporation | $30.75 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $25.09 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.03 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.25 | 2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.99 | 2019 | |
| Organon LLC | $12.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timu Kwi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.